FDA-approved historically for osteoporosis and hypogonadism (withdrawn 1985 — market not safety decision). Historically most-studied oral anabolic steroid. Limited modern human clinical trials. Historical clinical research base from 1960s–1980s.
17α-alkylated testosterone derivative. C1-C2 double bond added for oral bioavailability and reduced androgenicity. Aromatizes to methylestradiol (more potent than estradiol). Strong anabolic effects — protein synthesis, glycogenolysis, nitrogen retention. Originally developed by CIBA for performance research in the 1950s.
17α-alkylated; FDA history (withdrawn 1985); strong protein synthesis; aromatizes to methylestradiol; historical clinical research base.
Research data is not a treatment plan. If you are considering Methandrostenolone, the questions that matter are whether it suits your history, your labs and your goals. That is a conversation with a licensed physician, not a lookup.
Speak with a physician LATOM Wellness is a physician-led telehealth practice. Consultation only. No compound is sold on this site.Interactive tools for this compound:
Reconstitution calculator · Full deep dive · Peptide fundamentals